학술논문
There is no difference in safety and efficacy with Tirofiban or Eptifibatide for patients undergoing treatment of large vessel occlusion and underlying intracranial atherosclerosis
Document Type
Article
Author
Source
In Interdisciplinary Neurosurgery: Advanced Techniques and Case Management March 2021 23
Subject
Language
ISSN
2214-7519